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MaBACKGROUND Hodgkin lymphoma (HL) survivors treated with thoracic radiation therapy (RT) have impaired exercise
tolerance and increased cardiovascular mortality.
OBJECTIVES The purpose of this study was to evaluate the prevalence of autonomic dysfunction and its implications
on exercise capacity and mortality in long-term survivors of HL.
METHODS Exercise parameters in 263 HL survivors referred for exercise treadmill testing at a median interval of 19
years after RT were compared with 526 age-, sex-, and cardiovascular risk score–matched control subjects. Within the RT
cohort, the presence of autonomic dysfunction, deﬁned by an elevated resting heart rate (HR) ($80 beats/min) and
abnormal heart rate recovery (HRR) at 1 min (#12 beats/min if active cool-down, or #18 beats/min if passive recovery),
was correlated with exercise capacity and all-cause mortality over a median follow-up of 3 years.
RESULTS RT was associated with elevated resting HR and abnormal HRR after adjusting for age, sex, cardiovascular risk
factors, medications, and indication for exercise treadmill testing: odds ratio: 3.96 (95% conﬁdence interval [CI]: 2.52
to 6.23) and odds ratio: 5.32 (95% CI: 2.94 to 9.65), respectively. Prevalence of autonomic dysfunction increased with
radiation dose and time from RT. Both elevated resting HR and abnormal HRR were associated with reduced exercise
capacity in RT patients. Abnormal HRR was also associated with increased all-cause mortality (age-adjusted hazard ratio:
4.60 [95% CI: 1.62 to 13.02]).
CONCLUSIONS Thoracic RT is associated with autonomic dysfunction, as measured by elevated resting HR and
abnormal HRR. These abnormalities are associated with impaired exercise tolerance, and abnormal HRR predicts
increased all-cause mortality in RT patients. (J Am Coll Cardiol 2015;65:573–83) © 2015 by the American College of
Cardiology Foundation.T horacic radiation therapy (RT) is associatedwith increased cardiovascular morbidityand mortality (1–3). In particular, delayed
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ABBR EV I A T I ON S
AND ACRONYMS
APMHR = age-predicted
maximal heart rate
AVN = atrioventricular node
BP = blood pressure
ETT = exercise treadmill test
HL = Hodgkin lymphoma
HR = heart rate
HRR = heart rate recovery
IHD = ischemic heart disease
METs = metabolic equivalents
RT = radiation therapy
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574(4,5). Although radiation-related injuries to
the coronary arteries, valves, myocardium,
and pericardium are well described, auto-
nomic injury has been suggested (6) but not
accurately quantiﬁed in HL survivors.
Furthermore, whether autonomic dysfunc-
tion contributes to impaired exercise toler-
ance and prognosis in HL survivors is
unknown.SEE PAGE 584Elevated resting heart rate (HR) and
abnormal heart rate recovery (HRR) after ex-
ercise are established markers of autonomicdysfunction (7) that are associated with cardiovascular
morbidity and mortality (8) and with all-cause mor-
tality in many patient populations (9–13). We exam-
ined the prevalence and functional and prognostic
signiﬁcance of elevated resting HR and abnormal HRR
in HL survivors treated with RT and referred for exer-
cise treadmill testing (ETT).
METHODS
STUDY POPULATION. We identiﬁed 498 survivors of
HL among 25,059 consecutive patients undergoing
ETT at the study institution between January 2003
and October 2013. Medical record review conﬁrmed
whether HL patients received thoracic RT before
ETT. Patients undergoing exercise protocols other
than the standard Bruce protocol and those in atrial
ﬁbrillation or paced rhythms at or during ETT were
excluded to yield 263 patients in the radiation
cohort. For every RT patient, 2 patients matched by
age, sex, and Morise clinical risk score were identi-
ﬁed from the ETT database to yield 526 control
subjects (Online Figure 1). The Morise score con-
siders age, sex, symptoms, tobacco use, hyperlipid-
emia, diabetes mellitus, hypertension, estrogen
status, body mass index, and family history of cor-
onary artery disease to assess the pretest probability
of coronary artery disease (14). Similar exclusion
criteria were applied to control patients. The Part-
ners Healthcare Institutional Review Board approved
this study.
RISK FACTOR ASSESSMENT. Demographic factors,
symptoms, cardiovascular risk factors, and medica-
tions were determined at the time of ETT by use of
structured patient interviews and medical chart
review. Ischemic heart disease (IHD) was deﬁned as
any history of myocardial infarction, coronary re-
vascularization, or angiographic coronary artery dis-
ease. Congestive heart failure was deﬁned as anydocumented history of heart failure, cardiomyopathy,
or loop diuretic use at the time of ETT. Hyperlipid-
emia included any history of hyperlipidemia or statin
use at the time of ETT. Diabetes was deﬁned as any
documented history of diabetes or current use of in-
sulin or oral hypoglycemic agents. Ongoing or prior
tobacco use deﬁned a positive smoking history.
Age at HL diagnosis, year of RT, interval from RT to
ETT, radiation ﬁeld, and anthracycline exposure were
determined from medical chart review. The dose of
thoracic RT was available for 183 of 263 (69.6%)
patients.
EXERCISE PROTOCOL. All patients underwent ETT
according to the standard Bruce protocol (15) without
interruption of baseline cardiac medications. HR
on the 12-lead electrocardiogram and manually
measured blood pressure (BP) were recorded at rest in
the supine position, after each 3-min stage of
exercise, at maximum exercise, and at 1, 3, and
5 min in recovery. Exercise was continued until
one or more of the following endpoints was re-
ached: exhaustion, symptom limitation, $85% of age-
predicted maximal HR (APMHR), $10 mm Hg
decline in systolic BP from baseline, sustained ven-
tricular tachycardia, ST-segment depression $3 mm
measured at 80 ms after the J-junction, or
ST-segment elevation $1 mm. ETTs performed as part
of stress myocardial perfusion imaging involved a
1-min active cool-down at 1.5 miles/h recovery pro-
tocol, whereas ETTs performed alone or during stress
echocardiography involved passive recovery in the
supine position. ETTs were performed, analyzed, and
reported according to international standards (16)
with the use of a computerized database.
ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT
VENTRICULAR DIASTOLIC FUNCTION. One hundred
ﬁfty-four of 263 (58.6%) RT patients had necessary
images acquired at resting transthoracic echocardio-
grams performed 0.6 (interquartile range [IQR]: 5.5 to
0.5) days before the index ETT to allow retrospective
quantiﬁcation of the following parameters: peak early
diastolic tissue velocity (E0) measured from the septal
and lateral mitral annulus, mitral inﬂow Doppler E-
and A-wave velocities, E/A ratio, and E-wave decel-
eration time. Left atrial volume was assessed by use
of the biplane area-length method at end systole from
apical 2- and 4-chamber views and indexed to body
surface area (17). These data were used in exploratory
subgroup analyses to evaluate the association of pri-
mary endpoints with diastolic function.
STUDY ENDPOINTS. Primary endpoints included
elevated resting HR and abnormal HRR at 1 min.
TABLE 1 Deﬁnition of Study Endpoints
Exercise Endpoint Deﬁnition
Primary endpoints
Elevated resting HR HR $80 beats/min at rest (10)
Abnormal HRR (HR at peak exercise – HR at 1 min of recovery)
#12 beats/min for ETTs involving an active cool-down
(11,31) and #18 beats/min for ETTs involving passive
recovery (31,32)
Secondary endpoints
METs Workload estimated from treadmill speed and grade
% APMHR achieved Where APMHR ¼ 220 beats/min – age (33)
Rate-pressure product Systolic BP  HR
Abnormal systolic BP response
to exercise
Exercise-induced decrease in systolic BP below standing
baseline value or failure to increase systolic BP by
$20 mm Hg from baseline during exercise (34)
Duke treadmill score Exercise time – (5  ST-segment deviation in mm)
– (4  exercise angina score: 0 ¼ none,
1 ¼ nonlimiting, and 2 ¼ exercise-limiting)
Score $þ5 ¼ low risk, –10 to þ4 ¼ moderate risk, and
#–11 ¼ high risk (35)
Chronotropic incompetence Failure to obtain $62% of adjusted HR reserve during
exercise for patients treated with beta-blockers
(36,37) or
failure to obtain $80% of adjusted HR reserve during
exercise for patients not treated with beta-blockers
(36,37)
Adjusted HR reserve ¼ (peak HR – resting HR)/(APMHR –
resting HR)
Abnormal reserve pulse pressure (Pulse pressure at peak exercise – pulse pressure at
rest) <44 mm Hg, where pulse pressure ¼ systolic
BP – diastolic BP (38)
APMHR ¼ age-predicted maximal heart rate; BP ¼ blood pressure; ETT ¼ exercise treadmill test; HR ¼ heart rate;
HRR ¼ heart rate recovery; METs ¼ metabolic equivalents.
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575Secondary endpoints included other exercise pa-
rameters with prognostic signiﬁcance in non-HL
populations. These were: 1) workload in metabolic
equivalents (METs); 2) percentage of APMHRachieved;
3) rate-pressure product; 4) abnormal systolic BP
response to exercise; 5) Duke treadmill score; 6) chro-
notropic incompetence; and 7) reserve pulse pres-
sure. The individual endpoints are deﬁned in Table 1.
FOLLOW-UP AND ALL-CAUSE MORTALITY. All-cause
mortality was assessed for the RT cohort through the
use of the Social Security Death Index in January
2014. The median follow-up period was 3.0 (IQR: 1.5
to 4.6) years after the index ETT.
STATISTICAL ANALYSIS. Continuous, normally dis-
tributed variables are presented as mean  SD and
compared by use of the Student t test. Continuous,
non-normal data are presented as median with inter-
quartile range and compared by use of the Wilcoxon
rank-sum test. Categorical variables are presented as
percentages and compared by use of the Fisher exact
test. HR and systolic BP measured at rest, at 3-minute
intervals during exercise, and in recovery were
compared between cohorts by use of separate Student
t tests without adjustments for repeated measures.
Study endpoints were dichotomized as normal or
abnormal on the basis of the deﬁnitions in Table 1.
Logistic regression was used to examine the rela-
tionship between RT and individual endpoints.
Multivariable logistic regression was used to control
for aggregate confounding by age, sex, cardiovascular
risk factors, medications, indication for ETT referral,
exercise performance, and anthracycline exposure.
The effects of radiation dose, interval from RT, radi-
ation ﬁeld, and anthracycline exposure on the asso-
ciation of primary endpoints with RT were explored in
subgroup analyses. Univariable linear regression was
used to assess the relationship between continuous
exercise HR and BP parameters and RT. Multiple
linear regression was used to control for potential
confounders. Multivariable logistic regression was
used to assess the relationship between the primary
endpoints and exercise performance in RT patients.
Cox proportional hazards regression models were
used to estimate the risk of all-cause mortality asso-
ciated with primary and secondary endpoints in
RT patients. The assumption of proportional hazards
was assessed on the basis of Martingale residuals.
Group survival rates were compared by use of the
log-rank test. To assess for bias introduced by IHD or
the use of atrioventricular nodal (AVN)-blocking
agents on the association between abnormal HRR and
all-cause death, analyses were repeated, censoring all
patients with a history of IHD or AVN-blocking med-
ications, respectively.All statistical analyses were performed with
the use of SAS version 9.3 (SAS Institute, Cary, North
Carolina). To adjust for multiple testing, a Bonferroni-
adjusted p value of <0.025 was considered statisti-
cally signiﬁcant.
RESULTS
BASELINE CHARACTERISTICS. Baseline characteris-
tics are shown in Table 2. RT patients were leaner and
had a higher prevalence of IHD, hyperlipidemia, and
statin use compared with that in control subjects. RT
patients received radiation at a mean age of 30.0 
12.4 years and underwent ETT at a median interval of
19 years (interquartile range [IQR]: 12 to 26 years)
after treatment. The median radiation dose was 38
Gy (IQR: 36 to 40 Gy), and 46% received concomitant
anthracycline chemotherapy. The neck was included
in the radiation ﬁeld for 220 of 263 (83.7%) patients
and excluded in 18 (6.8%) patients treated with
mediastinal RT only. Neck radiation could not be
conﬁrmed for the remaining 25 (9.5%) patients who
received involved ﬁeld RT.
ELECTROCARDIOGRAPHIC CHANGESWITH EXERCISE
TESTING. Control patients more frequently under-
went ETT for evaluation of chest pain or arrhythmias,
TABLE 2 Baseline Characteristics of the Study Population
Radiation Patients
(n ¼ 263)
Control Patients
(n ¼ 526) p Value
Age, yrs 49.9  11.0 49.7  10.8 0.77
Male 121 (46.0) 228 (43.4) 0.49
BMI, kg/m2 26.3  5.6 27.7  6.0 0.002
Cardiovascular risk factors
Hypertension 78 (30.0) 171 (32.5) 0.47
Diabetes mellitus 14 (5.3) 34 (6.5) 0.64
Hyperlipidemia 130 (49.4) 203 (38.6) 0.005
Family history of IHD 90 (46.2) 174 (45.9) 1.00
Smoking history 13 (4.9) 43 (8.2) 0.11
Congestive heart failure 26 (9.9) 60 (11.4) 0.55
Ischemic heart disease 41 (15.6) 52 (9.9) 0.03
Morise score 9 (3 to 12) 9 (4 to 12) 0.92
Cardiovascular medications
Beta-blocker 58 (22.1) 120 (22.8) 0.86
Calcium-channel blocker 18 (6.8) 41 (7.8) 0.70
ACE inhibitor 33 (12.6) 79 (15.0) 0.39
Diuretic 23 (8.8) 54 (10.3) 0.53
Statin 96 (36.5) 146 (27.8) 0.01
Age at time of RT, yrs 30.0  12.4 — —
Interval from RT to ETT, yrs 19 (12–26) — —
Total radiation dose, Gy 38 (36–40) — —
Adjuvant anthracycline
chemotherapy
121 (46.0) — —
LV ejection fraction, %* 59.0  5.3 — —
Values are mean  SD, n (%), or median (interquartile range). *LV ejection fraction available for
226 of 263 (86%) RT patients.
ACE ¼ angiotensin-converting enzyme; BMI ¼ body mass index; ETT ¼ exercise treadmill test;
IHD ¼ ischemic heart disease; LV ¼ left ventricle; RT ¼ radiation therapy.
TABLE 3 Heart Rate
for Radiation and Con
Primary endpoints
Elevated resting hea
Heart rate at rest,
Elevated heart rat
$80 beats/min
Abnormal heart rate
Heart rate recover
Abnormal heart ra
Secondary endpoints
Heart rate response
Heart rate reserve
Chronotropic incom
Blood pressure respo
Abnormal systolic
response
Abnormal reserve
Values are mean  SD or n
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576whereas the majority of RT patients (71.1%) were
referred for indications other than symptom evalua-
tion, including elective post-radiation cardiovas-
cular screening (Online Table 1). Despite differencesand Blood Pressure Responses to Matched Levels of Exercise
trol Cohorts
Radiation Patients
(n ¼ 263)
Control Patients
(n ¼ 526) p Value
rt rate
beats/min 78  12 68  12 <0.0001
e at rest, 117 (44.5) 94 (17.9) <0.0001
recovery
y at 1 min, beats/min 23  13 33  14 <0.0001
te recovery at 1 min 84 (31.9) 49 (9.3) <0.0001
to exercise
, beats/min 81  25 90  23 <0.0001
petence 49 (18.6) 102 (19.4) 0.85
nse to exercise
blood pressure 52 (19.8) 61 (11.6) 0.003
pulse pressure 146 (55.5) 243 (46.2) 0.017
(%).in referral indications, RT patients were more
likely to have positive ETTs (17.9% vs. 7.4%,
p < 0.0001), and a greater proportion had moderate
or high-risk Duke treadmill scores compared with
control subjects (19.4% vs. 12.6%, p ¼ 0.01) (Online
Table 1).
PRIMARY ENDPOINTS. Rest ing HR. RT patients had
a signiﬁcantly higher resting HR than did matched
control subjects (78  12 beats/min vs. 68  12 beats/
min, p < 0.0001) (Table 3). The resting HR distribution
for each cohort is shown in Figure 1A. Crude and
adjusted odds ratios (OR) for the association between
RT and elevated resting HR are presented in Table 4.
These associations remained signiﬁcant after
excluding patients with a history of IHD (Online
Table 2). Stratiﬁed analyses demonstrated effect
modiﬁcation of this association by sex: RT was asso-
ciated with a crude OR for elevated resting HR of
6.22 (95% conﬁdence interval [CI]: 4.00 to 9.67;
p < 0.0001) for women and 1.90 (95% CI: 1.10 to 3.27;
p ¼ 0.02) for men. Although there were no signiﬁcant
differences in the median dose of RT or interval from
RT to ETT between men and women, women were
signiﬁcantly younger than men at the time of RT (28 
11 years vs. 32  14 years; p ¼ 0.006).
Abnormal HRR. RT patients had a greater frequency
of abnormal HRR than did matched control subjects
(31.9% vs. 9.3%, p < 0.0001) (Table 3). The HRR dis-
tributions for each cohort are presented in Figure 1B.
The crude and adjusted ORs for the association be-
tween RT and abnormal HRR are presented in Table 4
and remained signiﬁcant after excluding patients
with a history of IHD (Online Table 2). There was no
evidence of effect modiﬁcation by sex in stratiﬁed
analyses.
SECONDARY ENDPOINTS. Exercise workload. Although
there were no differences in exercise duration, METs,
or percentage of APMHR achieved between the 2 co-
horts, the rate-pressure product at peak exercise was
signiﬁcantly lower among RT patients (25,065  5,459
vs. 26,411  5,794; p ¼ 0.002) (Online Table 1).
Importantly, in RT patients, exercise duration was
signiﬁcantly reduced among those with an elevated
resting HR (9.2  2.9 min vs. 10.7  3.1 min;
p < 0.0001) and those with abnormal HRR (8.3 
3.1 min vs. 10.6  2.9 min; p < 0.0001). Elevated
resting HR and abnormal HRR were associated with
a 1.1  0.3–min (p ¼ 0.001) and a 1.0  0.4–min
(p ¼ 0.006) reduction in exercise duration, respec-
tively, after adjusting for age, sex, cardiovascular
risk factors, medications, indication for ETT, and
ETT result. In similar adjusted analyses, elevated
resting HR and abnormal HRR were associated with
FIGURE 1 Frequency Distribution Histograms and Kernel Density Plots
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Frequency distribution histograms (blue bars) and kernel density plots (red broken curves)
for (A) resting heart rate (HR) and (B) heart rate recovery (HRR) at 1 minute for control and
radiation cohorts. Radiation patients had a higher resting HR and a lower HRR at 1 min after
completion of exercise compared with control subjects. Normal distribution curves (solid
salmon curves) are included.
TABLE 4 Unadjusted and Adjusted Odds Ratios for the Association of the
Primary and Secondary Endpoints With Radiation Therapy
Unadjusted Adjusted
OR (95% CI) p Value OR (95% CI) p Value
Primary endpoints
Elevated resting heart rate 3.68 (2.65–5.12) <0.0001 3.96 (2.52–6.22)* <0.0001
Abnormal heart rate recovery
at 1 min
4.57 (3.09–6.76) <0.0001 5.32 (2.94–9.66)† <0.0001
Secondary endpoints
Heart rate reserve (lowest tertile) 2.15 (1.57–2.93) <0.0001 3.20 (1.64–6.27)† 0.0007
Chronotropic incompetence 0.95 (0.65–1.39) 0.85 1.57 (0.87–2.84)† 0.14
Abnormal systolic BP response 1.88 (1.25–2.81) 0.003 1.44 (0.76–2.71)‡ 0.26
Abnormal reserve pulse pressure 1.45 (1.08–1.96) 0.02 1.41 (0.90–2.23)‡ 0.14
*Adjusted for age, sex, Morise risk score, diabetes, indication for ETT, AVN-blocking medications, congestive
heart failure/IHD, and anthracycline exposure. †Adjusted for age, sex, Morise risk score, diabetes, indication for
ETT, AVN-blocking medications, congestive heart failure/IHD, resting HR, exercise time, result of ETT, and
anthracycline exposure. ‡Adjusted for age, sex, Morise risk score, diabetes, indication for ETT, antihypertensive
medications, congestive heart failure/IHD, resting HR, exercise time, result of ETT, and anthracycline exposure.
AVN ¼ atrioventricular nodal; BP¼ blood pressure; ETT¼ exercise treadmill test; IHD¼ ischemic heart disease.
J A C C V O L . 6 5 , N O . 6 , 2 0 1 5 Groarke et al.
F E B R U A R Y 1 7 , 2 0 1 5 : 5 7 3 – 8 3 Autonomic Dysfunction in Radiation Survivors
577a 1.1  0.4 (p ¼ 0.002) and a 1.0  0.4 (p ¼ 0.007)
reduction in METs achieved among RT patients,
respectively.
Heart rate response to exerc i se . Although mean
HR at rest and at stages 1 through 3 of exercise was
greater in the RT cohort compared with that in control
subjects, there was no difference in the peak HR
achieved (Figure 2A). Although, HR reserve was
signiﬁcantly lower in the RT cohort, the prevalence of
chronotropic incompetence was similar between
cohorts (Table 3).
Blood pressure response to exerc i se . Resting
systolic and diastolic BP were similar between RT and
control patients: 121  16 mm Hg versus 124  17
mm Hg (p ¼ 0.07) and 75  9 mm Hg versus 76  10
mm Hg (p ¼ 0.10), respectively. However, the systolic
BP response at all stages of exercise was blunted in
RT patients compared with that in control subjects
(Figure 2B). Furthermore, RT patients were more
likely to have an abnormal systolic BP response to
exercise and abnormal reserve pulse pressure
compared with that in control subjects (Table 3).
Crude and adjusted ORs for the association between
RT and key exercise parameters for all patients (n ¼
789) and for those without a history of IHD (n ¼ 696)
are presented in Table 4 and Online Table 2,
respectively.
Left ventr i cu lar d iasto l i c funct ion . Left ventric-
ular diastolic echocardiographic parameters and
indexed left atrial volumes compared among RT pa-
tients with normal versus elevated resting HR and
with normal versus abnormal HRR are presented in
Online Table 3. Absolute E/E0 ratios were signiﬁcantly
higher among RT patients with abnormal HRR
compared with those with normal HRR: lateral E/E0
10.08 (IQR: 7.05 to 12.52) versus 6.98 (IQR: 5.96 to
9.03), p ¼ 0.002, and septal E/E0 11.80 (IQR: 9.47 to
16.69) versus 9.25 (IQR: 7.68 to 12.19), p < 0.001. No
such differences in E/E0 ratios were identiﬁed within
RT patients with or without an elevated resting HR.
Var iat ion in pr imary endpoints wi th interva l
f rom RT, dose of rad iat ion , rad iat ion ﬁeld , and
anthracyc l ine exposure . RT patients were divided
into tertiles on the basis of interval from RT to ETT.
Frequency of elevated resting HR and abnormal HRR
increased with time from RT (Figure 3). Every 5-year
increase in interval from RT was associated with a
1.0  0.4 beats/min (p ¼ 0.01) increase in resting HR
and a 1.5  0.4 beats/min (p < 0.0001) decline in HRR
after adjusting for age, sex, body mass index, dia-
betes, IHD, congestive heart failure, AVN-blocking
agents, result of ETT, and exercise time.
Radiation dose was available for 69.6% of the RT
cohort; the median dose of 38 Gy was used to
FIGURE 2 Heart Rate and Systolic Blood Pressure Response to Exercise
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578dichotomize patients into low-dose (n ¼ 91, dose ¼ 36
Gy [IQR: 31 to 36 Gy] and high-dose cohorts (n ¼ 92,
dose ¼ 40 Gy [IQR: 40 to 42 Gy]). Prevalence of
elevated resting HR did not differ between high- and
low-dose patients (56.7% vs. 43.3%, p ¼ 0.10), even
after adjusting for age, sex, and AVN-blocking agents(OR: 1.74; 95% CI: 0.90 to 3.37; p ¼ 0.10). However,
the prevalence of abnormal HRR was signiﬁcantly
higher in the high-dose group (46.7% vs. 14.3%,
p < 0.0001), even after adjusting for age, sex, and
AVN-blocking agents (OR: 4.02; 95% CI: 1.90 to
8.47; p ¼ 0.0003).
Prior neck radiation was associated with an
increased likelihood of both elevated resting HR and
abnormal HRR compared with patients treated with
mediastinal radiation alone (OR: 4.04; 95% CI: 1.24 to
15.64; p ¼ 0.01 and OR: 9.71; 95% CI: 1.26 to 74.37;
p ¼ 0.008, respectively).
There was no signiﬁcant independent association
between anthracycline exposure and elevated resting
HR or abnormal HRR in adjusted analyses.
Al l -cause morta l i ty and surv iva l ana lyses .
Nineteen of 263 (7.2%) RT patients died over a median
follow-up of 3.0 (IQR: 1.5 to 4.6) years. Elevated
resting HR was not associated with mortality in this
group. However, abnormal HRR was associated with
an increased risk of death: unadjusted hazard ratio ¼
5.50 (95% CI: 1.97 to 15.36; p ¼ 0.001) (Figure 4, Online
Figure 2). Age- and sex-adjusted hazard ratios for
this association were 4.60 (95% CI: 1.62 to 13.02;
p ¼ 0.0005) and 6.24 (95% CI: 2.20 to 17.70;
p ¼ 0.0002), respectively. Unadjusted, age-adjusted,
and sex-adjusted hazard ratios for the secondary
endpoints are presented in Online Figure 2.
After excluding patients with IHD (n ¼ 41, 15.6%),
11 of 222 (5.0%) RT patients died over a median
follow-up of 3.0 (IQR: 1.6 to 4.6) years. Abnormal HRR
remained signiﬁcantly associated with mortality in
this IHD-naive cohort (hazard ratio: 6.32; 95% CI:
1.67 to 23.91; p ¼ 0.007). Similarly, after excluding
patients receiving AVN-blocking agents (n ¼ 73,
27.8%), 9 of 190 (4.7%) patients died over a median
period of 3.0 years (IQR: 1.6 to 4.7 years), and ab-
normal HRR remained signiﬁcantly associated with
mortality (hazard ratio: 9.06; 95% CI: 1.85 to 44.43];
p ¼ 0.007). Furthermore, abnormal HRR predicted
mortality after adjusting for left ventricular ejection
fraction among 226 RT patients with echocardio-
graphic data available (hazard ratio: 12.31; 95% CI:
2.76 to 54.80; p ¼ 0.001).
DISCUSSION
HL survivors treated with thoracic RT are at in-
creased risk for cardiovascular morbidity and mor-
tality (2,18). Although the risk of premature IHD,
valvular disease, and myopericardial disease is
clearly recognized, autonomic dysfunction has not
been well described in these patients. To our
FIGURE 3 Prevalence of Elevated Resting Heart Rate and
Abnormal Heart Rate Recovery
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579knowledge, this is the ﬁrst study to demonstrate that
RT is associated with an elevated resting HR and
abnormal HRR compared with that in matched con-
trol subjects in a large cohort of HL survivors.
Autonomic dysfunction increases with time from RT
and is independent of other cardiac risk factors and
established cardiovascular disease. Survivors of RT
with an elevated resting HR or abnormal HRR
have reduced exercise capacity on ETT. Further-
more, abnormal HRR predicts all-cause mortality,
which suggests that autonomic dysfunction may
contribute to the adverse outcomes seen in HL
survivors of RT (Central Illustration).
The autonomic nervous system regulates the he-
modynamic response to exercise (19,20). Para-
sympathetic tone predominates in the resting state.
Hemodynamic compensation during initial exercise
is mediated by parasympathetic withdrawal, fol-
lowed by sympathetic activation as exercise pro-
gresses. Prompt restoration of parasympathetic tone
after cessation of exercise and subsequent adren-
ergic withdrawal mediate HRR (21). Autonomic
dysfunction is characterized by attenuated para-
sympathetic and increased sympathetic activity. In
this study, HL survivors had a higher prevalence of
autonomic dysfunction, as evidenced by a higher
resting HR and abnormal HRR compared with that in
radiation-naive control subjects. Moreover, RT pa-
tients had a blunted systolic BP response to exercise,
a potential further indication of autonomic abnor-
malities. These ﬁndings agree with a prior study of
48 childhood HL survivors showing an elevated
resting HR on ambulatory Holter monitoring and
a blunted HR or BP response to exercise (6).
We demonstrated progressive autonomic dysfunc-
tion with increasing interval from RT. Additionally,
higher doses of RT predisposed to abnormal HRR.
These observations suggest possible dose-related
radiation-mediated injury of the autonomic nervous
system, with a progressive and late manifestation
over time. Given the increased prevalence of
elevated resting HR and abnormal HRR in patients
with neck radiation, it is likely that injury at
the level of the vagus nerve/carotid sinus is the
dominant contributor to the observed autonomic
dysfunction. However, given the small number
of patients who received mediastinal RT alone
(n ¼ 18), we are cautious to avoid conclusive
statements regarding the mechanism of injury.
Furthermore, the interval from RT to ETT was much
longer in patients with neck exposure: 21 years
(IQR: 15 to 28 years) versus 10 years (IQR: 8 to 11
years), p < 0.0001. This difference reﬂects recent
changes in HL treatment practices to limitunnecessary radiation exposure and may confound
the observed differences between patients with and
those without neck RT.
In childhood HL survivors, elevated resting HR is
associated with self-reported exercise limitation on
quality-of-life questionnaires (6). Although there
were no differences in overall exercise capacity be-
tween RT patients and control subjects, elevated
resting HR and abnormal HRR were associated with
impaired exercise performance within RT patients.
These data provide novel evidence that autonomic
dysfunction might contribute to objective functional
limitation in RT survivors. Additionally, we cannot
exclude the possibility that diastolic dysfunction, as
suggested by our limited echocardiographic analyses,
might have also contributed to the impaired exercise
performance seen in patients with autonomic abnor-
malities. Others have previously shown an association
between autonomic abnormalities and diastolic
dysfunction (22). Although the mechanisms remain
poorly understood, autonomic inﬂuences on myocar-
dial calcium handling might adversely inﬂuence left
ventricular relaxation (23) and exercise tolerance in
RT patients.
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580Autonomic dysfunction is associated with in-
creased mortality in patients with coronary artery
disease and congestive heart failure and in asymp-
tomatic patients at risk for cardiovascular disease
(10,11,24–26). In this study, abnormal HRR was asso-
ciated with a 5-fold-higher age-adjusted risk of death
among RT patients. Although we failed to demon-
strate an association between elevated resting HR and
mortality, other studies have shown that an elevated
resting HR is an independent predictor of sudden
(10), cardiovascular (13), and all-cause (10,12) death in
nonradiation patients. Limited sample size and short
follow-up duration probably prevented us from
detecting an association between elevated resting HR
and mortality. We also evaluated other established
exercise parameters known to predict adverse out-
comes in nonradiation cohorts. Exercise time, failure
to achieve $85% APMHR, Duke treadmill score,
chronotropic incompetence, abnormal systolic BP
response, and abnormal pulse pressure reserve were
each predictive of all-cause mortality in RT patients.
These ﬁndings validate the prognostic utility of ETT
in this patient population.
STUDY LIMITATIONS. The retrospective nature of
this study poses several inherent limitations. We
cannot exclude selection bias in both the RT and
control patients referred for ETT. However, this is the
largest study to date that evaluates hemodynamic
responses to exercise after thoracic RT and thus
provides novel information regarding autonomicabnormalities in these patients. The recovery proto-
col varied according to whether ETT was performed
in isolation or as part of a stress imaging study;
however, the deﬁnitions of HRR applied were test-
speciﬁc to account for this variability. We were
also unable to assess other validated measures of
autonomic dysfunction such as HR variability (27).
Our ability to detect differences in exercise toler-
ance of RT and control patients was limited, given
that physical exhaustion was not the exercise
endpoint for all patients. However, similar exercise
performance in the RT and exercise cohorts sug-
gests that exercise conditioning was comparable
between groups. Furthermore, we were able to
demonstrate reduced exercise performance in RT
patients with evidence of autonomic dysfunction.
We were unable to detect a dose-response rela-
tionship between RT and elevated resting HR, given
the narrow range of radiation doses observed in
this study (IQR: 36 to 40 Gy). In addition, data on
thoracic radiation dose were available for only
69.6% of patients, given the long interval from RT to
ETT and/or off-site treatment in some cases with
the associated challenges in medical record retrieval.
Echocardiographic data were not available for all
patients, which limited our ability to fully quantify
the contribution of diastolic function to the abnormal
functional capacity noted in this study. All-cause
mortality was assessed through the use of the Social
Security Death Index, which has inherent limitations.
The low number of deaths during the limited follow-
up in the RT cohort restricted the number of con-
founders that could be controlled for simultaneously
in survival analyses and limited meaningful evalu-
ation of causes of death. Regardless, we were able to
demonstrate the prognostic signiﬁcance of abnormal
HRR after controlling for age, sex, IHD, left ventric-
ular ejection fraction, and AVN-blocking agents,
individually.
CLINICAL IMPLICATIONS. These ﬁndings have im-
portant clinical implications for the evaluation and
management of HL survivors treated with thoracic
RT. First, it is important for clinicians to appreciate
the increased prevalence of autonomic dysfunction
in this patient population. Second, these abnormal-
ities may contribute to the reduced exercise toler-
ance experienced by these patients (28,29). Third,
abnormal HRR after thoracic RT identiﬁes patients at
increased risk of all-cause mortality who may warrant
further evaluation. Last, the potential beneﬁt of in-
terventions that modulate adrenergic tone such as
beta-blockers, angiotensin-converting enzyme in-
hibitors, and structured exercise training should be
evaluated in future clinical trials (30). Although we do
CENTRAL ILLUSTRATION Autonomic Dysfunction in Radiation Survivors
Cardiovascular consequences of radiation therapy (RT) contributing to increased cardiovascular morbidity and mortality in survivors of Hodgkin lymphoma. RT patients
have increased prevalence of elevated resting heart rate and abnormal heart rate recovery relative to controls. These abnormalities contribute to decreased exercise
tolerance, and abnormal heart rate recovery is associated with increased mortality among RT patients. AV ¼ atrioventricular; SA ¼ sinoatrial.
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581not necessarily endorse routine exercise testing,
as currently recommended in a consensus statement
(39), attention to abnormalities in autonomic func-
tion may allow clinicians to identify higher-risk pa-
tients even in the absence of overt cardiovascular
symptoms.
CONCLUSIONS
Survivors of HL treated with thoracic RT demons-
trate higher resting HR and an increased propensity
for abnormal HRR compared with that in age-
matched, sex-matched, and clinical risk score–
matched control subjects. These observations suggestthat sympathovagal imbalance may be secondary to
radiation-mediated injury of the autonomic nervous
system. Furthermore, objective exercise capacity is
reduced in the presence of autonomic dysfunction,
and abnormal HRR predicts increased all-cause mor-
tality among RT patients. Further studies are required
to evaluate therapeutic interventions that modulate
this sympathovagal imbalance.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Survivors
of mantle and mediastinal radiation therapy for Hodgkin
lymphoma have a higher prevalence of elevated resting
heart rate (HR) and abnormal HR recovery after exercise
compared with a control group of individuals who have
not undergone radiation therapy. These variables are
associated with diminished exercise capacity, and
abnormal HR recovery is associated with increased
mortality among radiation therapy survivors.
TRANSLATIONAL OUTLOOK: Further studies are
needed to evaluate the impact on clinical outcomes of
therapeutic interventions that affect autonomic mecha-
nisms and HR responses in survivors of mediastinal and
mantle radiation therapy.
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